Alpha Crest Capital Management LLC Care Dx, Inc. Transaction History

Alpha Crest Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $13,426 - $22,062	-836 Reduced 2.45%	33,332 $567,000
Q2 2022 Aug 11, 2022	BUY	$20.49 - $39.72 $472,642 - $916,221	23,067 Added 207.79%	34,168 $734,000
Q1 2022 May 12, 2022	BUY	$28.19 - $46.6 $139,258 - $230,204	4,940 Added 80.18%	11,101 $411,000
Q4 2021 Feb 09, 2022	SELL	$41.2 - $73.6 $62,047 - $110,841	-1,506 Reduced 19.64%	6,161 $280,000
Q3 2021 Nov 10, 2021	BUY	$59.15 - $91.99 $249,790 - $388,473	4,223 Added 122.62%	7,667 $486,000
Q2 2021 Aug 12, 2021	SELL	$63.02 - $95.11 $181,308 - $273,631	-2,877 Reduced 45.51%	3,444 $315,000
Q1 2021 May 13, 2021	SELL	$57.62 - $95.6 $109,074 - $180,970	-1,893 Reduced 23.05%	6,321 $430,000
Q4 2020 Feb 12, 2021	SELL	$41.43 - $77.09 $327,255 - $608,933	-7,899 Reduced 49.02%	8,214 $595,000
Q3 2020 Nov 12, 2020	BUY	$30.88 - $37.94 $497,569 - $611,327	16,113 New	16,113 $611,000
Q4 2019 Feb 12, 2020	SELL	$19.24 - $28.41 $396,343 - $585,246	-20,600 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$20.03 - $40.08 $412,618 - $825,648	20,600 New	20,600 $466,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.